No takes yet. Share an insight, caveat, or question.
Molecular analysis reveals extensive novel pncA mutations in resistant Mycobacterium tuberculosis isolates, highlighting genetic sequencing for rapid pyrazinamide susceptibility screening.
Marttila et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: